Pre‐analytical guidelines for blood and CSF Biomarkers 2025: Recommendations from the NACC ADRC Biofluid Biomarker Best Practices Workgroup
Alzheimer's & Dementia · 2026-05 · 22 (5)
DOI: 10.1002/alz.71252 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Alzheimer's & Dementia, online erschienen am 04.05.2026. Verfasst von Timothy E Van Meter und 21 weiteren Autor:innen. Beteiligte Einrichtung: BRAINBox Solutions, , Inc., Richmond, Virginia, USA. Hauptthemen laut MEDLINE: Biomarkers, Alzheimer Disease, Specimen Handling, Practice Guidelines as Topic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS.
Abstract (Originalsprache)
The Biofluid Biomarkers Best Practices Workgroup of the National Alzheimer's Coordinating Center–Alzheimer's Disease Research Center (ADRC) Biomarker Core Steering Committee was convened to update pre‐analytical handling guidelines for biofluid biomarkers, focusing on cerebrospinal fluid (CSF) and blood. We reviewed current literature pertinent to best practices for biomarker studies and surveyed the ADRCs for biomarker analytes, platforms, and protocols used at each center. Across 37 ADRCs, 16 CSF and 28 plasma/serum analytes were reported to be studied at multiple centers. The pre‐analytical handling steps and concerns related to each, as supported by empirical studies and expert opinion, were integrated to generate a revised guideline document. The guideline aimed to standardize steps in biospecimen and biomarker analyte collection, storage, and pre‐analytical handling across the ADRCs. The 2025 ADRC guidelines represent the current working knowledge on biomarker best practices, providing guidance and harmonized protocols, and promoting robust analysis and reporting of composite data.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- BRAINBox Solutions, , Inc., Richmond, Virginia, USA.
- Department of Neurology & Neurological Sciences, Stanford University, Stanford, California, USA.
- Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Department of Physiology and Neuroscience, Alzheimer's Therapeutic Research Institute, Keck School of Medicine of the University of Southern California, San Diego, California, USA.
- Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California, USA.
- NCRAD, Indiana University School of Medicine, Indianapolis, Indiana, USA.
ORCID-Profile: Timothy E Van Meter, Robert A Rissman, Rachael Wilson, Thomas S Wingo, Lynn M Bekris, Thomas K Karikari
Förderung
- NIA NIH HHS
Zitieren
APA
Van Meter, T. E., Wilson, E. N., Elahi, F., Rissman, R. A., Lago, A. L., Faber, K., Gauthreaux, K., Osorio, R., Perkins, M., Gray, N., Morris, J., Liu, A., Stockwell, H., Kukull, W., Wilson, R., Wingo, T. S., Kanaan, N. M., Russ, K., Wilcock, D., …, & Karikari, T. K. (2026). Pre‐analytical guidelines for blood and CSF Biomarkers 2025: Recommendations from the NACC ADRC Biofluid Biomarker Best Practices Workgroup. Alzheimer's & Dementia, 22(5). https://doi.org/10.1002/alz.71252
Vancouver
Van Meter TE, Wilson EN, Elahi F, Rissman RA, Lago AL, Faber K, et al. Pre‐analytical guidelines for blood and CSF Biomarkers 2025: Recommendations from the NACC ADRC Biofluid Biomarker Best Practices Workgroup. Alzheimer's & Dementia. 2026;22(5). doi:10.1002/alz.71252
BibTeX
@article{VanMeter2026,
author = {Van Meter, Timothy E and Wilson, Edward N and Elahi, Fanny and Rissman, Robert A and Lago, Argentina Lario and Faber, Kelley and Gauthreaux, Kathryn and Osorio, Ricardo and Perkins, Matthew and Gray, Nora and Morris, Jill and Liu, Andy and Stockwell, Hannah and Kukull, Walter and Wilson, Rachael and Wingo, Thomas S and Kanaan, Nicholas M and Russ, Kristen and Wilcock, Donna and Biber, Sarah A and Bekris, Lynn M and Karikari, Thomas K},
title = {Pre‐analytical guidelines for blood and CSF Biomarkers 2025: Recommendations from the NACC ADRC Biofluid Biomarker Best Practices Workgroup},
journal = {Alzheimer's & Dementia},
year = {2026},
volume = {22},
number = {5},
doi = {10.1002/alz.71252}
}
EUVIMED